It’s an eye-popping number: $1.9 billion. It’s what Massachusetts spent last year on drugs prescribed to patients covered by MassHealth, and it’s nearly double what it was in 2012.
Gov. Charlie Baker’s budget for the coming year includes a plan to disrupt the trend, a move he says will save $80 million.
It starts with direct price negotiations. Baker says the proposal is aimed at 20 drugs pending approval or recently approved by the FDA.